30 Apr 2026
Ipragliflozin exerts anti-fibrotic effects via a novel multi-pathway mechanism: Targeting TLR4/NF-κB /TGF-β1 cascadePublisher siteThe International Journal of Biochemistry & Cell Biology, Liver physiology and pathology
Active, last published 2026
In antibiotics pharmacokinetics and efficacy
Nehal A.
Afifi
Scholar“Research focused on Antibiotics Pharmacokinetics and Efficacy and adjacent fields.”
Cairo University
Egypt
Claim Your ProfileEgypt13
H-index
779
Citations
Nehal has not officially claimed their profile. If you are Nehal, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ehal A. Afifi is a researcher working on Antibiotics Pharmacokinetics and Efficacy. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Nehal's work has been cited 779 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Antibiotics Pharmacokinetics and Efficacy×10Drug-Induced Hepatotoxicity and Protection×9Liver Disease Diagnosis and Treatment×7Liver physiology and pathology×7Antibiotic Resistance in Bacteria×4
04 · Where I am
Affiliations
Affiliation on published researchCairo University, EgyptDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
1 workExpert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Nehal?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you